Drugs / nitroglycerine
nitroglycerine
Trials 10 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 02 trials | ||||||
| Phase 0 | NCT04110808 | Oct 2019 → Jan 2020 | — | Beni-Suef University | Unknown | No outcome recorded |
| Phase 0 | NCT02993640 | Sep 2016 → Mar 2017 | portal hypertension | Sahlgrenska University Hospital | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00535808 | Oct 2007 → Mar 2011 | — | University Hospital, Ghent | Completed | No outcome recorded |
| Phase 43 trials | ||||||
| Phase 4 | NCT02832115 | Sep 2016 → May 2019 | coronary vasospasm | Aultman Health Foundation | Completed | No outcome recorded |
| Phase 4 | NCT00484133 | Jun 2007 → Dec 2008 | infectious disease with sepsis | Onze Lieve Vrouwe Gasthuis | Unknown | No outcome recorded |
| Phase 4 | NCT00449059 | Jan 2003 → Dec 2004 | hypertensive disorder | University of Zurich | Completed | No outcome recorded |
| Phase not applicable4 trials | ||||||
| — | NCT05310929 | Aug 2019 → Mar 2022 | severe pre-eclampsia | Ain Shams University | Completed | No outcome recorded |
| — | NCT02258620 | Jun 2013 → Sep 2014 | coronary artery disorder | Brugmann University Hospital | Completed | No outcome recorded |
| — | NCT00541736 | Oct 2007 → May 2008 | familial hemiplegic migraine | Danish Headache Center | Completed | No outcome recorded |
| — | NCT00185887 | Oct 2003 → Jul 2006 | fetal brain disruption sequence | Stanford University | Completed | No outcome recorded |
Also used as a comparator or background therapy in 13 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT04030663 Comparator | Feb → Sep 2019 | — | Kasr El Aini Hospital | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01242306 Comparator | Mar → Nov 2009 | — | Azienda Ospedaliera San Camillo Forlanini | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT01715220 Comparator | Oct 2014 → Dec 2018 | biliary tract disorder | United States Naval Medical Center, San Diego | Unknown | No outcome recorded |
| Phase 2 | NCT01185951 Comparator | Jan 2007 → Aug 2010 | disease of the tendon, epicondylitis | Hannover Medical School | Unknown | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT02115256 Comparator | Jul 2014 → Apr 2015 | — | Yaakov Beilin | Terminated | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00554853 Background | Nov 2007 → Oct 2012 | rheumatoid arthritis | University of Michigan | Completed | No outcome recorded |
| Phase 43 trials | ||||||
| Phase 4 | NCT05122780 Comparator | Jul 2021 → Jul 2025 overdue | myocardial infarction | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Active not recruiting | No outcome recorded |
| Phase 4 | NCT02280850 Background | Oct 2014 → Jun 2015 | intermediate coronary syndrome | Shaanxi Buchang Pharmaceutical Co., Ltd | Unknown | No outcome recorded |
| Phase 4 | NCT00707928 Comparator | Feb 2008 → Dec 2010 | placenta disorder | Mahidol University | Completed | No outcome recorded |
| Phase not applicable4 trials | ||||||
| — | NCT06265415 Comparator | Mar 2024 → Mar 2025 | severe pre-eclampsia | Sohag University | Unknown | No outcome recorded |
| — | NCT05241054 Comparator | Mar → Sep 2022 | lacrimal duct obstruction | Mansoura University | Unknown | No outcome recorded |
| — | NCT03569046 Comparator | Jul → Dec 2018 | — | Abd-Elazeem Abd-Elhameed Elbakry | Completed | No outcome recorded |
| — | NCT03422354 Comparator | Feb → May 2018 | — | Cairo University | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 23 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nitroglycerine | “Group N received nitroglycerine intravenous infusion in a concentration of 1 mg/ml, thus 1µg/Kg/min equals to 4.8 ml/hr for an 80 Kg patient.” NCT05310929 ↗22“hypotensives for deliberate hypotension by nitroglycerine 0.5-10 μg /kg/min and increments of 0.2 mg propranolol” NCT03569046 ↗ “vasopressin infusion 4,8 U/h for 20 minutes, thereafter nitroglycerine infusion to a MAP of 60 for 5 minutes.” NCT02993640 ↗ “Topical nitroglycerine (Nitrolingualspray(R)) 2x2 hubs per day over 6 months daily on the painful tendon” NCT01185951 ↗ “2mg of isosorbide dinitrate or bolus 250microg of nitroglycerine will be infused by intracoronary bolus” NCT01242306 ↗ “hypotensive drugs ( propranolol and nitroglycerineand the total dose will be recorded.” NCT03422354 ↗ “Nitroglycerine 400 micrograms intravenously for intrapartum fetal resuscitation.” NCT00185887 ↗ “i.e. nitroglycerine; dosages titrated on blood pressure, ECG, heart rate” NCT05122780 ↗ |
| Known as | nitroglycerin | “Patients will receive hypotensive anesthesia with nitroglycerine infusion via syringe pump by adding 5mg (5ml) of Nitroglycerin to 45ml of normal saline making it to final...” NCT04110808 ↗1“Sublingual nitroglycerin is most commonly used for treatment of chest pain related to insufficient cardiac perfusion.” NCT01715220 ↗ |
| Known as | Nitrolingualspray(R) | “Topical nitroglycerine (Nitrolingualspray(R)) 2x2 hubs per day over 6 months daily on the painful tendon” NCT01185951 ↗ |
| Known as | TNG | “infusion of Nitroglycerine (TNG) (0.2-1µg/kg/min) will be started and adjusted to maintain mean arterial blood pressure between 55-65mmHg.” NCT05241054 ↗ |
| Known as | Topical Nitroglycerine | “Topical Nitroglycerine is applied to wrist prior to transradial cardiac catheterization to dilate radial artery and reduce spasm in study arm patients” NCT02832115 ↗ |
| Route | Other | “infusion of nitroglycerine into the pulmonary artery” NCT00449059 ↗ |